1.	Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: 040152, 04-C-0152, NCT00080353
2.	Phase I Study of Fowlpox gp100 Antigen Vaccination and Antitumor Antigen T-Cell Receptor (TCR)-Gene Engineered Tumor Infiltrating Lymphocytes or CD8+ Autologous Peripheral Blood Lymphocytes Followed by Interleukin-2 in Lymphodepleted Patients With Metastatic Melanoma Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-04-C-0181, NCI-6470, 6470, NCT00085462